Can you weigh in on the controversy about whether universal cervical screening should be performed with transvaginal ultrasonography for all women at their anatomy scan? Am J Perinatol 2016; 33[5]:473-9). I suspect studies like these will inform practice.
Question 3:
You mention that Dutch women who are induced with an unfavorable cervix have a much higher rate of vaginal delivery when compared to American women (85% compared with 63%, respectively). Do you think this is because women in the Netherlands are given more time to labor or is epigenetics playing a role? 
is useful for guiding management on labor and delivery because the negative predictive value of a transvaginal cervical length of >30 mm is high (96%-100%), as is the preterm birth risk with a very short (<20 mm) cervix. In the case of a 20-29 mm cervix, other factors (gestational age, fetal fibronectin) must be taken into account (see Am J Obstet Gynecol 2016;215:B2-7).
Response from Dr. Feltovich:
Question 5:
It's incredible to think that in antiquity, membrane stripping was routinely practiced and successful in inducing labor, and that this was recently validated in modern times. Would you recommend that membrane stripping routinely be added to an obstetrician's arsenal and performed at term to help induce labor and hopefully decrease the rate of cesarean deliveries? The world of "precision" medicine is amazing. In cancer research, scientists have access to the cancer cells in the form of a tumor. As you depicted in Figure 4 of the article, biomarkers during pregnancy can be found in serum and cervicovaginal fluid. Is there a biological model that mimics pregnancy and the various physiologic changes that occur to the tissue during pregnancy that can be assessed in a similar way to cancer cells?
Yes, isn't that incredible? The best part of writing this Clinical Expert

Question 7:
You mention ultrasonic attenuation and shear wave speed can access the softness of the cervix. If one of these modalities becomes a useful biomarker, can this technology easily be implemented into practice in the office or on labor and delivery?
Yes, and perhaps even in the near future. One of the issues with these technologies is that the typical curvilinear transvaginal transducer does not work well for these applications in the cervix. Because of that, our group has been working with prototype transducers, which are not at all easy. However, commercial transducers are under development, and this will make implementation possible.
Response from Dr. Feltovich:
To my knowledge, the answer is no at the present moment, but that is precisely what we and many other groups are working toward.
Question 8:
With the advent of precision medicine, do you think we will be able to make predictions for women before they are even pregnant, or will each individual fetus also impact the molecular signature to such a degree that conception must come first?
I suspect both that we will be able to tell a lot before a woman is even pregnant, and that each individual fetus will design its own molecular signature. Biology is extremely variable (and fascinating)! So many groups are actively engaged in this problem, and technology has advanced so much, that I truly think the next 10 years will see more progress in the space of parturition science than have the last 2,000. It will be exciting for sure.
